Positive Trial of Methotrexate in Hand OA Has Modest Results

A randomized controlled trial of methotrexate in inflammatory hand OA demonstrated clinical benefit, suggesting a potential role for immunosuppression in a subset of patients with an inflammatory OA phenotype.

Related Keywords

Norway , Melbourne , Victoria , Australia , Monash , South Australia , Oslo , Michigan , United States , Amandae Nelson , Flavia Cicuttini , Idak Haugen , Musculoskeletal Unit At Monash University , National Health , Health Assessment Questionnaire , Diakonhjemmet Hospital Center , American College Of Rheumatology , Research Council Of Australia , Treat Hand Osteoarthritis , Musculoskeletal Unit , Monash University , Alfred Hospital , American College , Australian Canadian , Functional Index , Hand Osteoarthritis , Michigan Hand Outcomes Questionnaire , North Carolina , Chapel Hill , Thurston Arthritis Research Center , Diakonhjemmet Hospital , Musculoskeletal Diseases , Medscape Medical , Medical Research Council , Osteoarthritis Oa , Steoarthritis Generalized , A Osteoarthritis , Egenerative Joint Disease Djd , Rthritis Degenerative , Eneralized Osteoarthritis , Degenerative Arthritis , Hands , Disease Modifying Antirheumatic Drugs Dmards , Mard Disease Modifying Antirheumatic Drug , Hands Osteoarthritis , Pain Management , Spain , Rheumatoid Arthritis , A , Arthritis , Oint Inflammati ,